Entero Healthcare Solutions, 544122, ENTERO Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,627.61
41.87
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,864.90
N/A
2.62

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
15.58

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
21.79

PAT CAGR (%)

10 Years
5 Years
3 Years

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

EV:EBITDA (Average)

8 Years
5 Years
3 Years

Earnings Forecasts:

(Updated: 22-11-2025)

Description 2024 2025 2026 2027
Adj EPS 21.8 35 49.92 59.33
P/E Ratio 48.75 30.36 21.29 17.91
Revenue 5095.78 6527.82 8323.82 10294.2
EBITDA 171.55 260.98 371.84 494.7
Net Income 94.82 148.08 208.08 258.05
ROA 3.76 5.35 6.62 7.93
P/B Ratio 2.68 2.45 2.20 1.94
ROE 5.64 8.14 10.57 11.4
FCFF -91.64 -57.34 -123.48 -24.69
FCFF Yield -1.9 -1.19 -2.56 -0.51
Net Debt 67.25 108.66 239.3 300.38
BVPS 396.28 432.98 483.2 547.63

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 83.22 112.83 -26.24% 79.35 122.38 -35.16% 72.30 106.56 -32.15% 101.15 76.59 32.07%
Expenses 95.80 118.91 -19.43% 93.06 124.23 -25.09% 84.24 115.75 -27.22% 111.63 85.08 31.21%
EBITDA -12.58 -6.08 - -13.71 -1.85 - -11.94 -9.19 - -10.48 -8.50 -
EBIDTM -15.12% -5.38% -17.27% -1.51% -16.51% -8.62% -10.36% -11.10%
Other Income 24.23 28.81 -15.90% 26.29 32.17 -18.28% 25.87 42.39 -38.97% 27.51 16.25 69.29%
Interest 0.71 0.39 82.05% 0.59 0.41 43.90% 0.35 5.61 -93.76% 0.37 4.73 -92.18%
Depreciation 3.32 2.13 55.87% 2.82 2.17 29.95% 2.16 1.73 24.86% 2.19 2.32 -5.60%
PBT 7.61 20.22 -62.36% 9.16 27.74 -66.98% -35.65 25.87 - 14.47 0.70 1,967.14%
Tax 1.91 4.89 -60.94% 2.21 6.87 -67.83% -7.85 -11.41 - 3.69 -0.25 -
PAT 5.70 15.33 -62.82% 6.96 20.88 -66.67% -27.81 37.28 - 10.78 0.95 1,034.74%
PATM 6.85% 13.59% 8.77% 17.06% -38.46% 34.98% 10.66% 1.24%
EPS 1.31 3.52 -62.78% 1.60 4.80 -66.67% -6.39 8.57 - 2.48 0.22 1,027.27%

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 1,570.95 1,300.69 20.78% 1,403.82 1,097.04 27.96% 1,339.06 1,034.18 29.48% 1,359.00 992.63 36.91%
Expenses 1,508.88 1,258.24 19.92% 1,353.75 1,066.86 26.89% 1,290.14 1,005.30 28.33% 1,308.98 964.03 35.78%
EBITDA 62.07 42.45 46.22% 50.07 30.17 65.96% 48.91 28.88 69.36% 50.01 28.60 74.86%
EBIDTM 3.95% 3.26% 3.57% 2.75% 3.65% 2.79% 3.68% 2.88%
Other Income 4.79 11.28 -57.54% 5.83 13.44 -56.62% 7.29 9.15 -20.33% 7.50 1.79 318.99%
Interest 12.40 11.46 8.20% 10.66 9.70 9.90% 10.49 17.32 -39.43% 9.97 16.07 -37.96%
Depreciation 9.83 7.49 31.24% 8.87 6.61 34.19% 8.49 7.14 18.91% 8.10 5.99 35.23%
PBT 44.63 34.78 28.32% 36.36 27.30 33.19% 37.23 13.56 174.56% 39.44 8.32 374.04%
Tax 8.03 8.74 -8.12% 6.13 6.77 -9.45% 5.80 -7.62 - 9.99 1.34 645.52%
PAT 36.60 26.03 40.61% 30.23 20.53 47.25% 31.42 21.18 48.35% 29.45 6.98 321.92%
PATM 2.33% 2.00% 2.15% 1.87% 2.35% 2.05% 2.17% 0.70%
EPS 7.26 5.43 33.70% 6.39 4.62 38.31% 5.90 4.82 22.41% 5.85 4.22 38.63%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 25 Mar 24 Mar 23 Mar 22
Net Sales 336.02 408.67 318.16 177.69 137.29 Net Sales Growth -19.68% 28.45% 79.05% 29.43% Cost Of Goods Sold 299.21 362.22 269.54 154.53 128.44 Gross Profit 36.81 46.45 48.62 23.16 8.85 GP Margin 10.96% 11.37% 15.28% 13.03% 6.45% Total Expenditure 384.73 439.02 352.65 221.61 191.00 Power & Fuel Cost - 0.89 0.87 0.66 0.57 % Of Sales - 0.22% 0.27% 0.37% 0.42% Employee Cost - 47.35 56.25 43.59 37.92 % Of Sales - 11.59% 17.68% 24.53% 27.62% Manufacturing Exp. - 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% General & Admin Exp. - 14.84 13.96 10.54 14.78 % Of Sales - 3.63% 4.39% 5.93% 10.77% Selling & Distn. Exp. - 10.52 8.57 10.37 8.72 % Of Sales - 2.57% 2.69% 5.84% 6.35% Miscellaneous Exp. - 3.19 3.46 1.90 0.58 % Of Sales - 0.78% 1.09% 1.07% 0.42% EBITDA -48.71 -30.35 -34.49 -43.92 -53.71 EBITDA Margin -14.50% -7.43% -10.84% -24.72% -39.12% Other Income 103.90 114.37 89.92 52.57 26.87 Interest 2.02 1.52 22.32 11.30 5.29 Depreciation 10.49 8.64 8.75 9.80 8.71 PBT -4.41 73.86 24.36 -12.46 -40.85 Tax -0.04 7.60 -14.07 0.00 0.00 Tax Rate 0.91% 28.38% -57.76% 0.00% 0.00% PAT -4.37 19.18 38.44 -12.46 -40.85 PAT before Minority Interest -4.37 19.18 38.44 -12.46 -40.85 Minority Interest 0.00 0.00 0.00 0.00 0.00 PAT Margin -1.30% 4.69% 12.08% -7.01% -29.75% PAT Growth -105.87% -50.10% - - EPS -1.00 4.41 8.84 -2.86 -9.39

Description TTM Mar 25 Mar 24 Mar 23 Mar 22
Net Sales 5,672.83 5,095.78 3,922.31 3,300.21 2,522.07 Net Sales Growth 28.21% 29.92% 18.85% 30.85% Cost Of Goods Sold 5,108.29 4,609.47 3,570.36 3,031.87 2,312.44 Gross Profit 564.54 486.31 351.96 268.34 209.63 GP Margin 9.95% 9.54% 8.97% 8.13% 8.31% Total Expenditure 5,461.75 4,924.23 3,810.47 3,236.20 2,497.63 Power & Fuel Cost - 7.20 5.59 4.25 4.07 % Of Sales - 0.14% 0.14% 0.13% 0.16% Employee Cost - 199.04 151.15 128.14 114.81 % Of Sales - 3.91% 3.85% 3.88% 4.55% Manufacturing Exp. - 1.38 1.29 1.26 1.22 % Of Sales - 0.03% 0.03% 0.04% 0.05% General & Admin Exp. - 39.47 34.36 30.08 28.85 % Of Sales - 0.77% 0.88% 0.91% 1.14% Selling & Distn. Exp. - 52.39 36.28 29.68 26.01 % Of Sales - 1.03% 0.92% 0.90% 1.03% Miscellaneous Exp. - 15.27 11.44 10.93 10.23 % Of Sales - 0.30% 0.29% 0.33% 0.41% EBITDA 211.06 171.55 111.84 64.01 24.44 EBITDA Margin 3.72% 3.37% 2.85% 1.94% 0.97% Other Income 25.41 39.51 14.41 5.51 4.48 Interest 43.52 41.62 65.68 48.97 28.98 Depreciation 35.29 30.69 25.02 24.24 19.75 PBT 157.66 138.74 35.55 -3.69 -19.81 Tax 29.95 31.30 -4.24 7.42 9.63 Tax Rate 19.00% 22.56% -11.93% -201.08% -48.61% PAT 127.70 94.82 39.11 -11.55 -29.92 PAT before Minority Interest 110.52 107.43 39.80 -11.10 -29.44 Minority Interest -17.18 -12.61 -0.69 -0.45 -0.48 PAT Margin 2.25% 1.86% 1.00% -0.35% -1.19% PAT Growth 70.90% 142.44% - - EPS 29.36 21.80 8.99 -2.66 -6.88

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 25 Mar 24 Mar 23 Mar 22
Shareholder's Funds 1,650.38 1,626.41 583.73 551.21 Share Capital 43.51 43.49 667.73 622.84 Total Reserves 1,602.64 1,581.15 -83.99 -71.64 Non-Current Liabilities 16.82 0.31 45.23 22.92 Secured Loans 0.00 0.00 28.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 Long Term Provisions 3.23 1.40 1.04 0.75 Current Liabilities 129.93 127.82 134.60 79.96 Trade Payables 86.05 64.90 55.75 34.75 Other Current Liabilities 43.01 61.28 14.02 12.17 Short Term Borrowings 0.00 0.00 63.50 30.00 Short Term Provisions 0.87 1.65 1.34 3.04 Total Liabilities 1,797.13 1,754.54 763.56 654.09 Net Block 28.29 34.44 40.65 51.42 Gross Block 73.40 72.11 69.63 72.17 Accumulated Depreciation 45.11 37.67 28.98 20.75 Non Current Assets 987.67 93.56 90.56 96.81 Capital Work in Progress 0.26 0.00 0.00 0.05 Non Current Investment 251.62 40.54 40.64 39.43 Long Term Loans & Adv. 701.84 13.51 7.87 5.91 Other Non Current Assets 5.66 5.06 1.40 0.00 Current Assets 809.46 1,660.98 673.00 557.27 Current Investments 25.76 0.00 0.00 0.00 Inventories 108.98 47.81 28.84 36.23 Sundry Debtors 99.86 113.19 74.48 52.23 Cash & Bank 170.06 792.35 77.19 88.24 Other Current Assets 404.81 97.08 56.68 38.89 Short Term Loans & Adv. 255.02 610.56 435.82 341.68 Net Current Assets 679.53 1,533.16 538.40 477.31 Total Assets 1,797.13 1,754.54 763.56 654.08

Description Mar 25 Mar 24 Mar 23 Mar 22
Shareholder's Funds 1,724.14 1,638.06 595.03 561.04 Share Capital 43.51 43.49 667.73 622.84 Total Reserves 1,676.40 1,592.79 -72.70 -61.80 Non-Current Liabilities 72.84 82.62 85.10 100.31 Secured Loans 0.00 45.54 31.07 37.13 Unsecured Loans 0.00 0.00 0.00 0.00 Long Term Provisions 9.64 7.11 5.40 4.43 Current Liabilities 845.02 601.95 623.96 461.78 Trade Payables 397.30 229.91 210.50 139.78 Other Current Liabilities 137.88 135.04 67.11 64.91 Short Term Borrowings 298.81 230.01 342.45 247.90 Short Term Provisions 11.02 6.98 3.90 9.19 Total Liabilities 2,688.21 2,325.96 1,306.72 1,125.30 Net Block 559.28 289.34 267.73 261.97 Gross Block 686.47 383.26 338.72 311.22 Accumulated Depreciation 127.19 93.93 70.99 49.25 Non Current Assets 612.50 314.97 283.55 274.42 Capital Work in Progress 0.26 0.00 0.00 0.64 Non Current Investment 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 47.16 20.20 14.42 11.81 Other Non Current Assets 5.80 5.44 1.40 0.00 Current Assets 2,075.71 2,010.97 1,023.17 850.88 Current Investments 57.55 0.00 0.00 0.00 Inventories 659.78 421.15 341.63 310.16 Sundry Debtors 830.36 615.40 514.88 374.60 Cash & Bank 260.42 893.18 106.84 105.40 Other Current Assets 267.60 40.52 23.17 24.35 Short Term Loans & Adv. 201.31 40.71 36.65 36.38 Net Current Assets 1,230.69 1,409.03 399.21 389.10 Total Assets 2,688.21 2,325.94 1,306.72 1,125.30

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 25 Mar 24 Mar 23 Mar 22
Cash From Operating Activity -109.02 -75.65 -56.91 -44.70 PBT 26.78 24.36 -12.46 -40.85 Adjustment -44.83 -38.43 -29.51 -9.38 Changes in Working Capital -74.31 -59.79 -12.41 6.49 Cash after chg. in Working capital -92.36 -73.86 -54.38 -43.74 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -16.65 -1.79 -2.53 -0.96 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity 207.74 -762.69 -58.29 -68.80 Net Fixed Assets -1.55 -2.48 2.59 Net Investments -236.84 0.10 -1.21 Others 446.13 -760.31 -59.67 Cash from Financing Activity -40.89 925.56 91.11 127.48 Net Cash Inflow / Outflow 57.84 87.22 -24.09 13.98 Opening Cash & Equivalents 93.34 6.12 30.20 16.22 Closing Cash & Equivalent 151.18 93.34 6.12 30.20

Description Mar 25 Mar 24 Mar 23 Mar 22
Cash From Operating Activity -76.87 -36.61 -45.31 -35.27 PBT 138.74 35.55 -3.69 -19.81 Adjustment 44.05 86.62 71.16 41.52 Changes in Working Capital -221.52 -145.73 -100.36 -46.07 Cash after chg. in Working capital -38.73 -23.55 -32.89 -24.36 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -38.14 -13.06 -12.43 -10.90 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity 219.80 -705.12 -48.59 -161.73 Net Fixed Assets -1.55 -2.48 2.59 Net Investments -236.84 0.10 -1.21 Others 458.19 -702.74 -49.97 Cash from Financing Activity -73.66 862.94 72.76 211.19 Net Cash Inflow / Outflow 69.27 121.21 -21.15 14.19 Opening Cash & Equivalents 147.65 25.36 46.51 32.31 Closing Cash & Equivalent 229.28 147.65 25.36 46.51

Financial Ratios

Standalone /

Consolidated

Description Mar 25 Mar 24 Mar 23 Mar 22
Book Value (Rs.) 378.35 373.53 -194.27 -176.06 ROA 1.08% 3.05% -1.76% -6.88% ROE 1.17% 4.98% 0.00% 0.00% ROCE 1.73% 4.06% -0.18% -6.66% Fixed Asset Turnover 5.62 4.49 2.51 2.04 Receivable days 95.14 107.65 130.14 110.45 Inventory Days 70.01 43.97 66.83 111.15 Payable days 76.05 81.69 106.88 67.76 Cash Conversion Cycle 89.10 69.92 90.10 153.84 Total Debt/Equity 0.00 0.00 0.16 0.05 Interest Cover 18.66 2.09 -0.10 -6.72

Description Mar 25 Mar 24 Mar 23 Mar 22
Book Value (Rs.) 395.31 376.21 -166.80 -150.52 ROA 4.29% 2.19% -0.91% -3.01% ROE 6.40% 5.08% 0.00% 0.00% ROCE 9.16% 7.02% 4.99% 1.24% Fixed Asset Turnover 9.53 10.87 10.16 9.53 Receivable days 51.78 52.59 49.19 44.63 Inventory Days 38.71 35.49 36.04 40.09 Payable days 24.83 22.51 21.08 18.67 Cash Conversion Cycle 65.66 65.57 64.15 66.06 Total Debt/Equity 0.17 0.17 0.63 0.51 Interest Cover 4.33 1.54 0.92 0.32

Top Investors:

surbhi singh(prasid uno family trust)

smallcap world fund, inc

invesco india aggressive hybrid fund

government of singapore

stichting depositary apg emerging markets equity pool

cif iii scheme i

csim india opportunities fund 1

Annual Reports:

FY 2025

FY 2024

FY 2023

News Update:

Entero Healthcare Solutions to acquire 80% stake in Bioaide Technologies
13th Nov 2025, 11:52 AM

The Board has also approved, inter-alia, entering into a binding Memorandum of Understanding for acquiring 51% stake in Anand Chemiceutics
Read More
Entero Healthcare Solutions gets nod to sell entire stake in Suprabhat
29th Sep 2025, 16:15 PM

The Board has also approved, inter-alia, to execute Share Purchase Agreement, for acquiring 60% stake in Ace Cardiopathy Solutions
Read More

Entero Healthcare Solutions Ltd.

Trading

BSE: 544122 | NSE: ENTERO

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

Entero Healthcare Solutions Ltd.

Trading

BSE: 544122 | NSE: ENTERO

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: